1.4(top 11%)
Impact Factor
1.6(top 11%)
extended IF
40(top 10%)
H-Index
196
authors
810
papers
9.7K
citations
204
citing journals
704
citing authors

Most Cited Articles of Quarterly Journal of Nuclear Medicine and Molecular Imaging

TitleYearCitations
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma200891
Bifunctional chelates for metal nuclides200888
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan201188
Prostate-specific membrane antigen as a target for cancer imaging and therapy201584
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy200479
Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions201079
New PET radiopharmaceuticals beyond FDG for brain tumor imaging201279
Labeled leukocyte imaging: current status and future directions200978
Biological subtypes of breast cancer: current concepts and implications for recurrence patterns201377
Dosimetry for treatment with radiolabelled somatostatin analogues. A review201073
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading201171
A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words200469
Imaging reporter genes for cell tracking with PET and SPECT200565
Imaging of infectious diseases using [18F] fluorodeoxyglucose PET200862
Lung metastases from differentiated thyroid carcinoma. A 40 years' experience200458
Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging200857
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM200953
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors200853
Radioimmunotherapy with alpha-particle emitting radionuclides200450
In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease200749
The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent200749
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study201149
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature200647
Advances in cancer therapy with radiolabeled monoclonal antibodies200647
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?200847